Transurethral Resection of Bladder Tumor

Transurethral resection of bladder tumor (TURBT) is a minimally invasive surgical procedure commonly used to diagnose and treat bladder cancer. It involves the removal of tumors from the bladder through the urethra, without the need for external incisions. This technique is typically used to treat superficial or early-stage bladder tumors that have not spread deeply into the bladder wall. TURBT is often the first line of treatment for patients diagnosed with bladder cancer and can be both diagnostic and therapeutic, helping to remove visible tumors and collect tissue samples for further analysis.

During the procedure, a cystoscope, a thin, flexible tube with a camera, is inserted into the bladder through the urethra. The surgeon can visualize the tumor and use specialized instruments to remove the tumor or tumor tissue. In some cases, the resection may be followed by the use of a laser or electric current to ensure complete removal of the tumor. TURBT not only helps in the diagnosis of bladder cancer by enabling the surgeon to assess the size and location of the tumor but also allows for the treatment of small or localized tumors, reducing the risk of further spread or recurrence.

TURBT is typically performed under general or spinal anesthesia, and the recovery time is generally shorter compared to more invasive surgeries. Most patients can go home the same day or after a short hospital stay. After the procedure, patients may experience temporary discomfort, including blood in the urine, a frequent urge to urinate, or mild pain. These symptoms usually resolve within a few days.

While TURBT is an effective procedure for treating early-stage bladder tumors, follow-up care is crucial. Bladder cancer has a high recurrence rate, so patients often require regular cystoscopies to monitor for any new growths or signs of recurrence. Depending on the extent of the tumor and the patient's individual case, additional treatments such as chemotherapy or immunotherapy may be recommended after TURBT to reduce the risk of cancer returning.

Overall, TURBT is a highly effective, minimally invasive option for treating bladder cancer, offering patients a faster recovery and a better quality of life compared to traditional open surgery. However, as with any surgical procedure, there are risks and potential complications, including bleeding or infection, and it is essential for patients to have a thorough consultation with their urologist to determine the best treatment approach for their condition.

The primary reason for performing TURBT is the presence of bladder cancer, though other conditions, such as bladder cysts or benign tumors, may also be treated through this method. Bladder cancer is the fourth most common cancer in men and occurs in the cells lining the bladder. The exact cause of bladder cancer is still unclear, but several risk factors are known to increase the likelihood of developing it:

Smoking is the most significant risk factor for bladder cancer. The carcinogens in tobacco smoke pass through the urine and damage the cells in the bladder, significantly increasing the risk of cancer.

Bladder cancer is more common in older adults, particularly those over the age of 55. Men are at a higher risk than women, with a ratio of 3:1 in favor of men.